Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India
Agency: Centers for Disease Control and Prevention - ERA
- 93.083 -- Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The purpose of this notice of funding opportunity (NOFO) is to support research to estimate the incidence of influenza and other respiratory viruses (such as SARS-CoV-2) among working-age adults and other priority populations in India to strengthen the evidence base and to help inform influenza vaccine policy in India. An additional goal is to identify risk factors that contribute to the influenza and/or SARS-CoV-2 burden in India to identify effective strategies to reduce disease burden. The overarching goal is to identify potential barriers to influenza and/or SARS-CoV-2 vaccination in the priority populations.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
FZP0@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| Foa_Content_of_RFA-IP-22-001.pdf | Foa_Content_of_RFA-IP-22-001.pdf | Mar 8, 2022 09:23 PM UTC |
Link to additional information
--
Archived: May 29, 2022
Award
$10,000,000
Program Funding
1
Expected awards
$1,500,000
Award Minimum
$2,000,000
Award Maximum
Funding opportunity number:
RFA-IP-22-001
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
2
Posted date:
March 8, 2022
Archive date:
May 29, 2022
